1Tsoukas C D, Lambris J D. Expression of EBV/C3d Recetor on Tcell:Biological Signficance[J].Immunol Today, 1993,14 (2) : 56-59.
2Borza C M, Hurt Fletcher L M. Alternate Replication in B Cells and Epithelial Cells Switches Tropism of Epstein-barr Virus[J].Nat Med,2002,8:594-599.
3Tan L C,Gudgeon N, Annels N E,et al. Are-evaluation of the Frequency of CD8^+ T-cells Specific for in Healthy Virus Carriers[J]. J Immunol, 1999,162:1827-1835.
4Harada S, Kieff E. Epstein-barr Virus Nuclear Protein LP Stimulates EBNA-2 Acidic Domain-mediated Transcriptional Activation[J].Virol, 1997,71(9):6611-618.
5Xin B, He Z, Yang X, et al. TRADD Domain of Epstein-barr Virus Transforming Protein LMP1 Isessential for Inducing Immortalization and Suppressing Senescence of Primary Rodent Fibroblasts[J]. Virol,2001,75(6) :3010-3015.
6Hofelamyr H, Stro L J, Marschall G, et al. Activated Notchl Can Transiently Substitute for EBNA2 in the Maintenance of Proliferation of LMPl-erpressing Immortalizerd Bcells [J]. Virol, 2001,75(5) :2033-2040.
10Bonnet M,Cuinebretiere J M,Kremmer E,et al. Detection of Epstein-barr Virus in Invasive Breast Cansers[J]. The National Cancer Institute, 1999,91(16):1376-1381.
5Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation [J]. Iht J Cancer, 1983,31 (1):13-20.
6Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms [J]. J Pathol, 1990, 162(4): 285-294.
7Mullerat J, Deroide F, Winslet MC, et al. Proliferation and p53expression in anal cancer precursor lesions [J]. Anticancer Res,2003, 23 (3C): 2995-2999.
8Liu M, Lawson G, Delos M, et al. Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations [J]. Head Neck,2003,25(4): 280-288.
9Tut VM, Braithwaite AL, Angus B, et al. Gyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53,wafl, pRb and Ki67 [J]. Br J Gancer,2001, 84(2): 270-275.
10Bhatavdekar JM, Patel DD, Shah NG,et al. Prognostic significance of immunohisto-chemically localized biomarkers in stage Ⅱ and stage Ⅲ breast cancer: a multivariate analysis [J] . Ann Surg Oncol,2000, 7 (4): 305-311.
